Dr. Amelie G. Ramirez, director of the Institute for Health Promotion Research (IHPR) at UT Health San Antonio and a leading health promotion researcher, will serve as the 2021-2022 chair of the the Women in Cancer Research Council of the American Association for Cancer Research (AACR). The council organizes the activities of the members of the Women in Cancer Research group. This includes fostering career development, recognizing scientific achievements, and advising AACR leadership. Ramirez is currently serving a three-year term on the council through December 2022. “It is a great honor to serve as chair of this group for the 2021-2022 term. Despite the challenges we have seen during the pandemic, I am proud to say we are still making strides and progressing in the field of ...
UT Health San Antonio is known for doing everything it takes. Everything it takes to treat COVID-19 patients, to change our teaching methods on a dime, to pass health provider exams on the first try, to partner in our community, and to find new cures for dreaded diseases. Our team at Salud America!, which is led by Dr. Amelie G. Ramirez at UT Health San Antonio, is excited to share the university's new “Everything It Takes” campaign. Ramirez is featured in the campaign. Visit EverythingItTakes.org. The campaign will have TV, radio, print, and digital ads. This includes Spanish-language materials, like this radio spot and this one. "We want all of San Antonio and South Texas to know that we’ll do 'Everything It Takes' to serve the health needs of patients in our region ...
Cancer can affect anyone. But Latinos experience higher rates of infection-related cancers, ones that are preventable, than their white peers, according to a new study from the American Cancer Society (ACS). In fact, Latinos suffer two times higher rates of liver and stomach cancers—infection-related but preventable cancers—than their white peers. “Addressing this critical gap for Hispanic individuals in obtaining access to high-quality cancer prevention, early detection and treatment is going to be essential for mitigating the predicted growth in the cancer burden,” wrote Kimberly Miller, an ACS scientist, in the report. “In addition, more research is needed to assess not only the impact of the COVID-19 pandemic on the utilization of cancer care, but also the impact ...
Did you know that every 65 seconds, someone develops Alzheimer’s disease? This number is most troubling for Latinos and women. Latinos overall are 1.5 times more likely to develop Alzheimer’s than their White peers. Two-thirds of Alzheimer’s patients are women. Latinas are at higher risk than non-Latinas. In response, the federal government created a website, Alzheimers.gov, for dementia information, resources, and clinical trials. Now that website is also in Spanish at Alzheimers.gov/es! Each website has: Information about Alzheimer’s disease and related dementias, including causes, symptoms, diagnosis, and treatment.
Knowledge and resources for caregivers and people living with dementia.
Clinical trials and studies that people can join to help advance ...
On Oct. 29, 2021, the FDA authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use for children ages 5 to 11. It had previously been approved for those ages 12 and older. The move will make the vaccine available to 28 million children in this age group. Getting children vaccinated is vital for controlling the spread of the pandemic, especially as many schools have returned to in-person learning. Do you have questions about the Pfizer vaccine and want to know more before your children get vaccinated? Here’s what Latino parents should know. Update 1/19/22: Greater than COVID shared new videos in English and Spanish featuring doctors answering questions about the COVID-19 vaccines for kids 5-11.
Is the vaccine safe for children? Why was it produced so ...
Latinas have lower rates of breast cancer than other groups. Sounds like good news, right? The bad news is that the Latina breast cancer rate has been rising over the past decade, and breast cancer is still the top cause of death for Latinas. Fortunately, we have clinical trials. Clinical trials are studies to find more effective treatments, which can help current cancer patients, and better understand cancer to help future Latino survivors. You can help the cause by volunteering for the Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer Clinical Trial at Mays Cancer Center at UT Health San Antonio. The trial, for women ages 18-100, including Latinas, aims to protect women against severe cases of breast cancer. “We need Latina volunteers for ...
By Roxy Harrison
Breast Cancer Survivor in San Antonio My name is Roxy Harrison and these are my miracle stories. My diagnosis story of both breast and ovarian cancer are a miracle! I noticed some discolouration under my right breast. I ignored it for a couple of months. It wouldn’t hurt but sometimes it would itch. I showed it to my primary care doctor. She said it’s probably just a heat rash, but if you’re concerned you can get a mammogram done. I was 37 so I wasn’t too worried. I did the mammogram, which I refer to as making pancakes. They call me back 2 weeks later that they want to do another one to compare. Why they would think something could change in 2 weeks is beyond me, but no problem. I do another one. Then they wanted me to do an ...
Are you a Latino cancer survivor?
Volunteer for the Avanzando Caminos study at UT Health San Antonio!
Avanzando Caminos aims to enroll 1,500 Latino cancer survivors in South Texas and 1,500 more in Miami to help unpack the social, cultural, behavioral, mental, biological, and medical influences on post-cancer life. The study is funded by the National Cancer Institute. The South Texas site is led by Dr. Amelie Ramirez of UT Health San Antonio and Mays Cancer Center. "With the help of Latino cancer survivors, we can help future Latino cancer survivors heal, recover, and reduce the chance for cancer to come back," said Ramirez, who also leads the Salud America! program at the Institute for Health Promotion Research at UT Health San Antonio. To volunteer for ask questions, go ...
Jeraldine Ortiz sabe que el cáncer de seno es difícil para las latinas. El cáncer de seno es la causa principal de muerte entre latinas. Esto se debe a las barreras culturales para la atención de salud, las bajas tasas de detección temprana y la baja participación en los estudios clínicos que buscan encontrar mejores tratamientos. Esta es la razón por la que Ortiz, cuando fue diagnosticada con cáncer de seno, decidió participar en un estudio clínico. Hoy, después de más de 15 años como sobreviviente de cáncer, Ortiz dijo que cree firmemente que su participación en un estudio clínico de UT Health San Antonio la ayudó a obtener un mejor tratamiento y una mejor calidad de vida después del cáncer. "Los estudios clínicos dan la oportunidad de un mejor ...
